The Europe Medical Image Analysis Software Market would witness market growth of 10.9% CAGR during the forecast period (2022-2028).
The key driver behind the market expansion is the development of medical image analysis software, a product of science and technology. Proteomics & genomics Imaging enables scientists to locate the disease-causing genetic mutations' biomarkers. The increase in market share is due to the requirement for medical image analysis to identify and diagnose diseases at an early stage.
For the dissemination of cutting-edge research findings in biological & medical image analysis for virtual robotics, computer vision, and biomedical imaging solutions, medical image analysis serves as a medium. The market expansion is anticipated by other variables, including the combination of imaging techniques and higher spending between the public and private sectors. The market's demand may be somewhat increased by the computer-aided diagnosis system's rising popularity.
The ability of medical image analysis software to achieve a variety of goals, including the development of tools with the capacity to analyze biomedical data and support the discovery with the improvement of biomedical knowledge, the innovation of computational methods to analyze and evaluate biomedical data using algorithms, and collaboration with colleagues from other research centers for the visualization of biomedical research problems, is the main factor driving the market growth.
The medical technology industry produces a $30 billion yearly turnover in the United Kingdom. A solid foundation of small & medium-sized businesses supports the region's medical technology industry. Many top American manufacturers of medical technology as well as numerous other global corporations, have their headquarters or subsidiaries in the country. The NHS's organization, scope, and complexity have increased the demand for a reliable digital healthcare infrastructure. To address the economic and social issues the NHS is experiencing, the UK government has determined that digitizing healthcare is essential. The expanding healthcare infrastructure in the region is estimated to support regional market growth.
The Germany market dominated the Europe Medical Image Analysis Software Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $423.4 million by 2028. The UK market is anticipated to grow at a CAGR of 10% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 11.7% during (2022 - 2028).
Based on Type, the market is segmented into Integrated and Standalone. Based on Modality, the market is segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Combined Modalities and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Neurology, Dental, Oncology and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Medical Image Analysis Software Market is Projected to reach USD 6.6 Billion by 2028, at a CAGR of 11.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Canon, Inc. (Canon Medical Systems Corporation), Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), Spacelabs Healthcare (OSI Systems, Inc.), Agfa-Gevaert Group, MIM Software, Inc., Esaote SpA, Aquilab SAS (Coexya), and Merative L.P. (Francisco Partner).
By Type
By Modality
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 